Ono Y et al. |
Antitumor and cytocidal activities of a newly isolated benzenoid ansamycin, macbecin I. |
1982 |
Gan |
pmid:6186564
|
Creech RH et al. |
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578). |
1982 |
Cancer Treat Rep |
pmid:6282460
|
Ratanatharathorn V et al. |
Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study. |
1982 |
Cancer Treat Rep |
pmid:7093975
|
Hatano K et al. |
Biosynthetic origin of aminobenzenoid nucleus (C7N-unit) of ansamitocin, a group of novel maytansinoid antibiotics. |
1982 |
J. Antibiot. |
pmid:7174527
|
Borden EC et al. |
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas. |
1982 |
Am. J. Clin. Oncol. |
pmid:6956236
|
Slavik M et al. |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience. |
1982 |
Am. J. Clin. Oncol. |
pmid:6897490
|
Edmonson JH et al. |
Phase II study of maytansine in advanced breast cancer. |
1981 May-Jun |
Cancer Treat Rep |
pmid:7237478
|
Schrek R and Stefani SS |
Toxicity of microtubular drugs to leukemic lymphocytes. |
1981 |
Exp. Mol. Pathol. |
pmid:7238845
|
Baskin F et al. |
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. |
1981 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6943568
|
Ikeyama S and Takeuchi M |
Antitubulin activities of ansamitocins and maytansinoids. |
1981 |
Biochem. Pharmacol. |
pmid:21043240
|